1. Noncoding RNAs in osteosarcoma: Implications for drug resistance
   Zhengjun Lin et al, 2021, Cancer Letters CrossRef
2. Predicting the Influence of MicroRNAs on Drug Therapeutic Effects by Random Walking
   Peng Xu et al, 2020, IEEE Access CrossRef
3. Role of MicroRNAs in Human Osteosarcoma: Future Perspectives
   Lola Llobat et al, 2021, Biomedicines CrossRef
4. MicroRNAs in Bone Diseases: Progress and Prospects
   Kah-Yung Bernard Leong et al, 2018, Transcriptional and Post-transcriptional Regulation CrossRef
5. Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
   Zhengxiao Ouyang et al, 2019, Cell Communication and Signaling CrossRef
6. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook
   Davide Selvestrel et al, 2021, Expert Review of Clinical Immunology CrossRef
7. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy
   Kazuki Heishima et al, 2019, BMC Veterinary Research CrossRef
8. MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects
   Leonardo Leonardi et al, 2021, Cells CrossRef
9. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR‐423‐5p to activate Wnt5a/Ror2 signaling
   Jun Wan et al, 2021, Cancer Science CrossRef
10. The Biological Role and Clinical Implication of MicroRNAs in Osteosarcoma
    Yutaka Nezu et al, 2017, Osteosarcoma - Biology, Behavior and Mechanisms CrossRef
11. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
12. Long noncoding RNA DNAJC3‐AS1 promotes osteosarcoma progression via its sense‐cognate gene DNAJC3
    Ridong Liang et al, 2019, Cancer Medicine CrossRef